LORATADINE TABLETS

The Defense Logistics Agency awarded a delivery order under the basic contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, with a total contract value of $200.10, for the procurement of 10,000 packages of loratadine tablets identified by NSN 6505013770448 and NDCs 00904-7511-61 and 51079-0246-20. The award was issued on July 14, 2026, with delivery required by July 29, 2026, to the destination address at Fort Bragg, North Carolina, under FOB Destination terms where the contractor is responsible for all shipping costs. The awardee is a certified Women-Owned Small Business with a CAGE code of 1UNB0, and the product is manufactured by two additional entities identified by CAGE codes 1LEZO and 3KJG9. The contract mandates shipment via traceable means only, with parcel post prohibited, and requires traceable control number W8002S51740157 to be marked on all packages. Invoicing must be submitted through the Wide Area WorkFlow system in accordance with DFARS 252.232-7003, with paymentsprocessed net 30 days to the remit-to address in Columbus, Ohio. Payment and administrative oversight is managed by DLA Troop Support Medical Supply Chain, with Shairy M. Cartagena as the primary point of contact. The contract does not specify detailed pharmaceutical standards such as USP or cGMP, nor does it reference MIL-STD packaging or marking requirements, though compliance with federal pharmaceutical regulations is implied. The small business status and WOSB certification trigger associated reporting obligations, and no options, modifications, or additional line items are included in this delivery order.